The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Abstract
Nitric oxide (NO·) is an important protective molecule in the vasculature, and endothelial NO· synthase (eNOS) is responsible for most of the vascular NO· produced. A functional eNOS oxidizes its substrate l -arginine to l -citrulline and NO·. This normal function of eNOS requires dimerization of the enzyme, the presence of the substrate l -arginine, and the essential cofactor (6 R )-5,6,7,8-tetrahydro- l -biopterin (BH 4 ), one of the most potent naturally occurring reducing agents. Cardiovascular risk factors such as hypertension, hypercholesterolemia, diabetes mellitus, or chronic smoking stimulate the production of reactive oxygen species in the vascular wall. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases represent major sources of this reactive oxygen species and have been found upregulated and activated in animal models of hypertension, diabetes, and sedentary lifestyle and in patients with cardiovascular risk factors. Superoxide (O 2 · − ) reacts avidly with vascular NO· to form peroxynitrite (ONOO − ). The cofactor BH 4 is highly sensitive to oxidation by ONOO − . Diminished levels of BH 4 promote O 2 · − production by eNOS (referred to as eNOS uncoupling). This transformation of eNOS from a protective enzyme to a contributor to oxidative stress has been observed in several in vitro models, in animal models of cardiovascular diseases, and in patients with cardiovascular risk factors. In many cases, supplementation with BH 4 has been shown to correct eNOS dysfunction in animal models and patients. In addition, folic acid and infusions of vitamin C are able to restore eNOS functionality, most probably by enhancing BH 4 levels as well.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The uncoupling causes eNOS activity to change from healthy (producing NO) to toxic (generating superoxide) (303).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [303]
In the citing paper
“Similarly, vascular disease, cardiovascular disease (CVD), and metabolic syndrome all share effective loss of NO function[23,35–39].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [23]
Citations
Cites
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,466
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001) · Circulation · doi:10.1161/hc4601.099485 · Cited by 1,961
Hypercholesterolemia increases endothelial superoxide anion production.
Ohara, Y., Peterson, T. E., & Harrison, D. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116491 · Cited by 1,765
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,652
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M. P., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,190
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,110
Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H. H. W., Nakane, M., & Murad, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10480 · Cited by 979
Ting, H. H., Timimi, F. K., Boles, K., Creager, S. J., Ganz, P., & Creager, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118394 · Cited by 869
Flagged first, then by citations
Research works printed but not linked: 23
- 10.1161/res.86.3.347 · DOI
- Li H Witte K August M Brausch I Gödtel-Armbrust U Habermeier A Closs EI Oelze M Münzel T Förstermann U. Reversal of eNOS uncoupling and upregulation of eNOS expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol. In press.
- 10.1161/res.88.2.e14 · DOI
- 10.1161/circ.99.15.2027 · DOI
- 10.1161/res.86.5.494 · DOI
- 10.1161/circ.94.11.2756 · DOI
- 10.1161/circ.101.11.1261 · DOI
- 10.1161/circ.100.21.2131 · DOI
- 10.1161/hyp.30.1.57 · DOI
- 10.1161/res.77.3.510 · DOI
- 10.1161/circ.103.9.1282 · DOI
- 10.1161/hyp.33.6.1353 · DOI
- 10.1161/res.86.1.e7 · DOI
- 10.1161/res.86.2.e36 · DOI
- 10.1161/circ.104.10.1119 · DOI
- 10.1161/res.87.2.99 · DOI
- 10.1161/res.87.7.566 · DOI
- 10.1161/hyp.38.5.1044 · DOI
- 10.1161/circ.104.22.2673 · DOI
- 10.1161/circ.94.1.6 · DOI
- 10.1161/circ.97.3.237 · DOI
- 10.1161/atvb.22.1.6 · DOI
- 10.1161/atvb.20.1.185 · DOI
Cited by
Sorted by citations
Items 701–800 of 1,003
Soares, R. N., Schneider, A., Valle, S. C., & Schenkel, P. C. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.03.002 · Cited by 35
Oloyo, A. K., Sofola, O. A., & Yakubu, M. A. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12595 · Cited by 35
Korkmaz, S., Radovits, T., Barnucz, E., Neugebauer, P., Arif, R., Hirschberg, K., Loganathan, S., Seidel, B., Karck, M., & Szabo, G. B. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.020 · Cited by 35
Alexander, L. M., Kutz, J. L., & Kenney, W. L. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00448.2012 · Cited by 35
“We have previously demonstrated that the hypercholesterolemia-induced microvascular dysfunction is mediated by a variety of mechanisms contributing to eNOS uncoupling where the eNOS dimer uncouples to produce superoxide instead of functional NO (7).”
BackgroundA Randomized Trial of Aspirin at Clinically Relevant Doses and Nitric Oxide Formation in Humans
Hennekens, C. H., Schneider, W. R., Pokov, A. N., Hetzel, S., DeMets, D. L., Serebruany, V. L., & Schröder, H. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410375091 · Cited by 35
“In high concentrations, NO inhibits the proliferation of smooth muscle cells.(5) More specifically, NO is released from vascular endothelium and plays a crucial role in the maintenance of vascular homeostasis.”
BackgroundRole of microRNAs 221/222 on Statin Induced Nitric Oxide Release in Human Endothelial Cells
Cerda, Á., Fajardo, C. M., Basso, R. D. G., Hirata, M. H., & Hirata, R. D. C. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20140192 · Cited by 35
Role of local production of endothelium-derived nitric oxide on cGMP signaling and S-nitrosylation
Qian, J., Zhang, Q., Church, J. E., Stepp, D. W., Rudic, R. D., & Fulton, D. J. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00614.2009 · Cited by 35
“Endothelium-derived nitric oxide (NO) as synthesized by endothelial nitric oxide synthase (eNOS) plays a vital role in maintaining cardiovascular homeostasis and has potent effects on vascular tone, smooth muscle cell proliferation and migration, leukocyte adhesion, and platelet aggregation (9).”
BackgroundGrau, M., Kollikowski, A. M., & Bloch, W. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-152039 · Cited by 35
Impaired Vascular Redox Signaling in the Vascular Complications of Obesity and Diabetes Mellitus
Akoumianakis, I., & Antoniades, C. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7421 · Cited by 37
“Intact eNOS function has been revealed as a major protective factor against vascular disease in obese and diabetic patients (126), something that comes to no surprise, considering the multitude of antioxidant, anti-inflammatory, vaso-dilatory, and antithrombotic effects of NO (49).”
Grandvuillemin, I., Buffat, C., Boubred, F., Lamy, E., Fromonot, J., Charpiot, P., Simoncini, S., Sabatier, F., Dignat‐George, F., Peyter, A., et al. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00354.2017 · Cited by 35
“In the vasculature, NO is mainly produced in endothelial cells by the enzyme eNOS, using L-Arg as a substrate and various co-factors, including tetrahydrobiopterin (BH4), flavin adenine dinucleotide, flavin mononucleotide, calmodulin and heme (1, 20, 27).”
BackgroundMao, X. W., Boerma, M., Rodriguez, D., Campbell-Beachler, M., Jones, T., Stanbouly, S., Sridharan, V., Nishiyama, N. C., Wroe, A. J., & Nelson, G. A. (2018) · Radiation Research · doi:10.1667/rr15219.1 · Cited by 36
“NO, which is derived from L-arginine in an oxidizing reaction catalyzed by NO synthase (NOS), serves multiple functions, including vasodilation, neurotransmission and immune defense (23).”
BackgroundRamesh, P., Caroline, M. L., Muthu, S., Narayana, B., Raja, M., & S, B. G. A. (2019) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2019.117190 · Cited by 35
Gorabi, A. M., Banach, M., Reiner, Ž., Pirro, M., Hajighasemi, S., Johnston, T. P., & Sahebkar, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091413 · Cited by 34
“Vascular nitric oxide (NO) is produced by endothelial nitric oxide synthase (eNOS) [135,136].”
BackgroundMoldogazieva, N. T., Mokhosoev, I. M., Melnikova, T. I., Zavadskiy, S. P., Kuzmenko, A. N., & Terentiev, A. A. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920140047 · Cited by 35
Sirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing
Zhang, H., Dai, Y., Zhang, C., Alfred, M. O., Ghosh, A., Khanra, I., Chakraborty, M., Yu, X., & Liang, J. L. (2020) · Biogerontology · doi:10.1007/s10522-020-09873-z · Cited by 35
Meng, P., Yang, R., Jiang, F., Guo, J., Lu, X., Yang, T., & He, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1481236 · Cited by 35
Sugar and Stroke: Cerebrovascular Disease and Blood Glucose Control
Quinn, T. J., Dawson, J., & Walters, M. R. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00166.x · Cited by 34
Helium Induces Preconditioning in Human Endothelium In Vivo
Smit, K., Oei, G. T. M. L., Brevoord, D., Stroes, E. S. G., Nieuwland, R., Schlack, W. S., Hollmann, M. W., Weber, N. C., & Preckel, B. (2012) · Anesthesiology · doi:10.1097/aln.0b013e3182751300 · Cited by 35
Plasma 3-nitrotyrosine, urinary 8-isoprostane and 8-OHdG among healthy Japanese people
Sakano, N., Takahashi, N. K., Wang, D.-H., Sauriasari, R., Takemoto, K., Kanbara, S., Sato, Y., Takigawa, T., Takaki, J., & Ogino, K. (2009) · Free Radical Research · doi:10.1080/10715760802663124 · Cited by 35
“oxidase, xanthine oxidase (XO) and release from mitochondria [4].”
BackgroundKar, S., & Kavdia, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.024 · Cited by 35
Ladurner, A., Schachner, D., Schueller, K., Pignitter, M., Heiß, E. H., Somoza, V., & Dirsch, V. M. (2014) · Molecules · doi:10.3390/molecules191016724 · Cited by 34
“Endothelial nitric oxide (NO), the product of the enzyme endothelial nitric oxide synthase (eNOS), is considered a major anti-inflammatory and anti-atherogenic mediator in the cardiovascular system [1].”
BackgroundMaintenance of Endothelial Guanosine Triphosphate Cyclohydrolase I Ameliorates Diabetic Nephropathy
Kidokoro, K., Satoh, M., Channon, K. M., Yada, T., Sasaki, T., & Kashihara, N. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012080783 · Cited by 34
Soucy, K. G., Lim, H. K., Attarzadeh, D. O., Santhanam, L., Kim, J. H., Bhunia, A. K., Sevinç, B., Ryoo, S., Vazquez, M. E., Nyhan, D. P., et al. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00946.2009 · Cited by 34
“In the endothelium, ROS is often correlated with diminished NO bioavailability, resulting in endothelial dysfunction (13, 16, 26, 52).”
BackgroundEl-Asrar, M. A., Andrawes, N. G., Ismail, E. A. R., & Salem, S. M. (2015) · Vascular Medicine · doi:10.1177/1358863x15591089 · Cited by 34
Antithrombotic effect and mechanism of Rubus spp. Blackberry
Xie, P., Zhang, Y., Wang, X., Wei, J., & Kang, W. (2017) · Food & Function · doi:10.1039/c6fo01717g · Cited by 34
Abdelghany, T. M., Ismail, R. S., Mansoor, F. A., Zweier, J. R., Lowe, F., & Zweier, J. L. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.02.009 · Cited by 34
Wang, B., Huang, C., Chen, L., Xu, D., Zheng, G., Zhou, Y., Wang, X., & Zhang, X. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01681 · Cited by 33
Okada, T., & Suzuki, H. (2020) · PubMed · doi:10.14670/hh-18-208 · Cited by 34
Zheng, S., Shi, A., Hill, S., Grant, C., Kokkinos, M. I., Murthi, P., Georgiou, H. M., Brennecke, S. P., & Kalionis, B. (2020) · Pregnancy Hypertension · doi:10.1016/j.preghy.2020.07.003 · Cited by 34
Leng, B., Li, C., Sun, Y., Zhao, K., Zhang, L., Lü, M., & Wang, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5070415 · Cited by 34
Nitric Oxide and Mechano-Electrical Transduction in Cardiomyocytes
Boycott, H. E., Nguyen, M., Vrellaku, B., Gehmlich, K., & Robinson, P. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.606740 · Cited by 35
Khanolkar, S., Hirani, S., Mishra, A., Vardhan, S., Hirani, S., Prasad, R., & Wanjari, M. B. (2023) · Cureus · doi:10.7759/cureus.42470 · Cited by 38
“The eNOS pathway is essential for maintaining vascular homeostasis and preventing the development of endothelial dysfunction [27].”
BackgroundWang, N.-P., Erskine, J., Zhang, W., Zheng, R., Zhang, L., Duron, G., Gendreau, J. L., & Zhao, Z. (2017) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320317706653 · Cited by 35
Yamashita, T., Yamamoto, E., Kataoka, K., Nakamura, T., Matsuba, S., Tokutomi, Y., Dong, Y., Ichijo, H., Ogawa, H., & Kim‐Mitsuyama, S. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.092049 · Cited by 34
Endothelial Dysfunction and Liver Cirrhosis: Unraveling of a Complex Relationship
Nesci, A., Ruggieri, V., Manilla, V., Spinelli, I., Santoro, L., Giorgio, A. D., Santoliquido, A., & Ponziani, F. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312859 · Cited by 34
Endothelial dysfunction in cardiovascular diseases: mechanisms and in vitro models
Grego, A., Fernandes, C., Fonseca, I., Dias‐Neto, M., Costa, R., Leite-Moreira, A. F., Oliveira, S. M., Trindade, F., & Nogueira‐Ferreira, R. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05289-w · Cited by 41
“A well-known endothelium-derived relaxing factor is NO [53], generated from L-arginine by the action of eNOS [54].”
Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease.
Wang, F., Lerman, A., & Herrmann, J. (2015) · Europe PMC (PubMed Central) · Cited by 33
Bhardwaj, P., Khanna, D., & Balakumar, P. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9226-y · Cited by 33
Lu, L., Wang, Y. N., Li, M. C., Wang, H. B., Pu, L. J., Niu, W. Q., Meng, H., Yang, E. L., Zhang, R., Zhang, Q., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs122 · Cited by 33
Mason, R. P., Jacob, R. F., Corbalan, J. J., Kaliszan, R., & Maliñski, T. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt202 · Cited by 32
Solini, A., Rossi, C., Duranti, E., Taddei, S., Natali, A., & Virdis, A. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.10.002 · Cited by 33
Bosche, B., Molčányi, M., Rej, S., Doeppner, T. R., Obermann, M., Müller, D. J., Das, A., Hescheler, J., Macdonald, R. L., Noll, T., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00593 · Cited by 34
“Maintenance of intracellular calcium homeostasis in cells of the vessel wall is a prerequisite for endothelium-mediated control of vascular tone (Förstermann and Münzel, 2006; RahimzadehRofouyi et al., 2007; Bosche et al., 2009, 2010, 2016) and preservation of the endothelial barrier (Garcia et al.”
InfluentialYan, M., Hou, M., Liu, J., Zhang, S., Liu, B., Xiao-xiong, W., & Liu, G. (2017) · Inflammation · doi:10.1007/s10753-017-0566-9 · Cited by 33
Hemolysis and Kidney Injury in Cardiac Surgery: The Protective Role of Nitric Oxide Therapy
Spina, S., Lei, C., Pinciroli, R., & Berra, L. M. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.06.008 · Cited by 35
Wu, Z., Yao, H., Xu, H., Wang, Y., Hu, W., Lou, G., Zhang, L., Huang, C., Jiang, C., Zhou, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74011-1 · Cited by 33
Natural Flavonoids Derived From Fruits Are Potential Agents Against Atherosclerosis
Li, R., Wang, L., Liu, S., Duan, H., Zhang, Q., Zhang, T., Peng, W., Huang, Y., & Wu, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.862277 · Cited by 36
Li, H., Song, D., Liu, Q., Li, L., Sun, X., Guo, J., Li, D., & Li, P. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00547-9 · Cited by 33
“However, NOS3, an indicator of endothelial cell injury, was elevated, suggesting that miR-351 silencing could provide endothelial cell protection (Förstermann and Münzel 2006).”
BackgroundMoreau, K. L., DePaulis, A. R., Gavin, K. M., & Seals, D. R. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00877.2006 · Cited by 33
“In addition to preventing superoxide reacting with nitric oxide, there is in vitro evidence that ascorbic acid also may influence nitric oxide production via modulation of endothelial nitric oxide synthase activity, possibly by influencing the bioavailability of a key cofactor for nitric oxide synthesis, tetrahydrobio…”
BackgroundKobayashi, T., Taguchi, K., Takenouchi, Y., Matsumoto, T., & Kamata, K. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.019 · Cited by 33
“which thereby causes an impairment of eNOS activities and a consequent endothelial dysfunction [27, 28 ,47].”
BackgroundModulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia
Chen, L., Okeke, E. S., Ayalew, D., Wang, D., Shahid, L., & Dokun, A. O. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217716424 · Cited by 33
Sherratt, S. C. R., Libby, P., Dawoud, H., Bhatt, D. L., & Mason, R. P. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034076 · Cited by 34
Fismen, L., Eide, T., Djurhuus, R., & Svardal, A. M. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.08.019 · Cited by 34
Riad, A. H., Westermann, D., Linthout, S. V., Mohr, Z., Uyulmaz, S., Becher, P. M., Rütten, H., Wohlfart, P., Peters, H., Schultheiss, H.-P., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1159-9 · Cited by 32
“VASP is a specific substrate of the cGK-1 in several cell lines including endothelial cells, which is activated by NO [5, 25].”
BackgroundInfluentialIda, S., Murata, K., Betou, K., Kobayashi, C., Ishihara, Y., Imataka, K., Uchida, A., Monguchi, K., Kaneko, R., Fujiwara, R., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0468-4 · Cited by 32
“Some researchers have reported a decrease in NO production or its activity in DM patients [5].”
BackgroundAl-Gburi, S., Deußen, A., Zatschler, B., Weber, S., Künzel, S. R., El‐Armouche, A., Lorenz, K., Cybularz, M., Morawietz, H., & Kopaliani, I. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0617-2 · Cited by 32
Engineered Nanoparticles for Effective Redox Signaling During Angiogenic and Antiangiogenic Therapy
Nethi, S. K., Barui, A. K., Mukherjee, S., & Patra, C. R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7383 · Cited by 32
“Detailed description of the formation of O 2 (cid:2) - from uncoupled eNOS has been explained by Forstermann and Munzel (70).”
Bernardi, S., Giudici, F., Barbato, V., Zanatta, L., Grillo, A., & Fabris, B. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab157 · Cited by 32
Bertani, F., Francesco, D. D., Corrado, M. D., Talmon, M., Fresu, L. G., & Boccafoschi, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413300 · Cited by 32
“Reduced bioavailability of NO is considered as one of the most important factors associated with vascular disease [54,55].”
BackgroundWright, J. R., Zhou, S., & Churg, A. (2012) · Inhalation Toxicology · doi:10.3109/08958378.2012.715698 · Cited by 32
Rajendran, S., & Chirkov, Y. Y. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6098-7 · Cited by 32
“Moreover, in view of the increased enzymatic activity of arginase, documented in animal models of cardiovascular disease and in human endothelial cells subjected to thrombin or inflammatory cytokines, a relative intracellular L-arginine deficiency is quite possible [46].”
BackgroundInfluentialVessières, E., Guihot, A., Toutain, B., Maquigneau, M., Fassot, C., Loufrani, L., & Henrion, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068217 · Cited by 35
“Dimerization of the enzyme is a key step in the production of NO [13,52] and eNOS dimerization is strongly reduced in ZDF rats’ mesenteric arteries [53].”
BackgroundThe chemical biology of nitric oxide — an outsider's reflections about its role in osteoarthritis
Feelisch, M. (2008) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(08)60007-2 · Cited by 32
Nikitopoulou, I., Orfanos, S. E., Kotanidou, A. N., Maltabe, V. A., Manitsopoulos, N., Karras, P., Kouklis, P. D., Armaganidis, A., & Maniatis, N. A. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00156.2014 · Cited by 32
Li, H., Yu, X., Bai, J., Su, Q., Wang, Μ., Huo, C.-J., Xia, W., Yi, Q.-Y., Liu, K., Fu, L., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.12.020 · Cited by 32
Ratnani, I., Ochani, R. K., Shaikh, A., & Jatoi, H. N. (2023) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1245 · Cited by 33
Kim, S. Y., & Cheon, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102446 · Cited by 33
Direct evidence that (−)-epicatechin increases nitric oxide levels in human endothelial cells
Brossette, T., Hundsdörfer, C., Kröncke, K., Sies, H., & Stahl, W. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0172-9 · Cited by 31
“Defects in generation of NO are associated with increased risk for cardiovascular disease [ 4 , 5]. Cardioprotective effects of cocoa, improvement of endothelial function, and lowering of blood pressure are attributed to flavanol-mediated elevation of the NO level [6, 7]. Vasodilatory activity was also observed after…”
Shen, K., Leung, S. W. S., Ji, L., Huang, Y., Hou, M., Xu, A., Wang, Z., & Vanhoutte, P. M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.007 · Cited by 31
Autocrine VEGF Isoforms Differentially Regulate Endothelial Cell Behavior
Yamamoto, H., Rundqvist, H., Branco, C. M., & Johnson, R. S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00099 · Cited by 31
“ORIGINAL RESEARCH published: 21 September 2016 doi: 10.3389/fcell.2016.00099 Frontiers in Cell and Developmental Biology | www.frontiersin.org 1 September 2016 | Volume 4 | Article 99 Edited by: Mitsugu Fujita, Kindai University, Japan Reviewed by: Helen Knowles, University of Oxford, UK Anca Maria Cimpean, “Victor Ba…”
BackgroundInfluentialLAV-BPIFB4 isoform modulates eNOS signalling through Ca2+/PKC-alpha-dependent mechanism
Spinelli, C., Carrizzo, A., Ferrario, A., Villa, F., Damato, A., Ambrosio, M., Madonna, M., Frati, G., Fucile, S., Sciaccaluga, M., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx072 · Cited by 31
Marrazzo, F., Spina, S., Zadek, F., Lama, T. T., Xu, C., Larson, G. M., Rezoagli, E., Malhotra, R. K., Zheng, H., Bittner, E. A., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026848 · Cited by 31
The Role of Antioxidants in the Prevention of Cadmium-Induced Endothelial Dysfunction
Almenara, C. C. P., de Oliveira, T. F., & Padilha, A. S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200415172338 · Cited by 29
Shnayder, N. A., Петрова, М. М., Викторовна, М. П., Shesternya, P. A., Пожиленкова, Е. А., & Nasyrova, R. F. (2021) · Molecules · doi:10.3390/molecules26061556 · Cited by 31
“In addition to NO production, eNOS can function in an uncoupled manner and produce ROS when the available stores of BH4 are removed or oxidized, l-arginine is depleted, or the eNOS inhibitor asymmetric dimethyl-l-arginine is overexpressed [9,10].”
BackgroundCai, S., Pan, N., Xu, M., Su, Y., Qiao, K., Chen, B., Zheng, B.-D., Xiao, M., & Liu, Z. (2021) · Marine Drugs · doi:10.3390/md19120655 · Cited by 32
“ROS-producing systems in the vascular wall are dominated by NADPH oxidase (NOX), xanthine oxidase (XO), and uncoupled nitric oxide synthase (NOS) and the uncoupling of eNOS contributes markedly to increased ROS production [58].”
BackgroundDesign of biodegradable 3D-printed cardiovascular stent
Veerubhotla, K., & Lee, C. H. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00204 · Cited by 32
Wang, Y., Li, Q., Zhang, Z., Peng, K., Zhang, D., Yang, Q., Passerini, A. G., Simon, S. I., & Sun, C. (2022) · Communications Biology · doi:10.1038/s42003-022-03653-w · Cited by 30
Sueta, D., Koibuchi, N., Hasegawa, Y., Toyama, K., Uekawa, K., Katayama, T., Ma, M., Nakagawa, T., Waki, H., Maeda, M., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.016 · Cited by 31
Teixeira, C. E., Priviero, F. B. M., & Webb, R. C. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124594 · Cited by 31
“Superoxide reacts with NO to form peroxynitrite and other reactive nitrogen species, resulting in a diminished NO bioavailability (Jeremy et al., 2002; Förstermann and Münzel, 2006).”
BackgroundLiaw, N., Fox, J. M., Siddiqui, A. H., Meng, H., & Kolega, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101721 · Cited by 31
“NO alters cell adhesion mechanisms in endothelial cells to prevent leukocyte attachment [34].”
BackgroundHomocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur
Eren, E. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/7827.4773 · Cited by 30
Oliveira‐Paula, G. H., Lacchini, R., Luizon, M. R., Fontana, V., Silva, P. S., Biagi, C., & Tanus-Santos, J. E. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.03.006 · Cited by 32
Krüger, R. L., Teixeira, B. C., Farinha, J. B., Macedo, R. C. O., Boeno, F. P., Rech, A., López, P., Pinto, R. S., & Reischak-Oliveira, Á. (2016) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2016-0262 · Cited by 31
Saito, Y., Kitahara, H., Nakayama, T., Fujimoto, Y., & Kobayashi, Y. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.45179 · Cited by 31
Role of endothelial-derived nitric oxide in hypertension and renal disease
Marin, E. P., & Sessa, W. C. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328017f893 · Cited by 31
Molecular, genetic and epigenetic pathways of peroxynitrite-induced cellular toxicity
Korkmaz, A., Öter, Ş., Seyrek, M., & Topal, T. (2009) · Interdisciplinary Toxicology · doi:10.2478/v10102-009-0020-4 · Cited by 31
“ISSN: 1337-6853 (print version) | 1337-9569 (electronic version) response and vascular events (Forstermann and Munzel, 2006; Pacher et al., 2007).”
Yu, E., Ruiz-Canela, M., Hu, F. B., Clish, C. B., Corella, D., Salas-Salvadó, J., Hruby, A., Fitó, M., Liang, L., Toledo, E., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3569 · Cited by 30
Diosmin and its glycocalyx restorative and anti‐inflammatory effects on injured blood vessels
Mitra, R., Nersesyan, A., Pentland, K., Melin, M. M., Levy, R. M., & Ebong, E. E. (2022) · The FASEB Journal · doi:10.1096/fj.202200053rr · Cited by 30
Tang, F., Liu, D., Zhang, L., Xu, L.-Y., Zhang, J., Zhao, X., Ao, H., & Peng, C. Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106953 · Cited by 32
Sulphur mustard induces time- and concentration-dependent regulation of NO-synthesizing enzymes
Steinritz, D., Elischer, A., Balszuweit, F., Gonder, S., Heinrich, A., Bloch, W., Thiermann, H., & Kehe, K. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.04.012 · Cited by 30
Potential role of antioxidants in the treatment of portal hypertension
Rodrı́guez-Vilarrupla, A., Bosch, J., & García‐Pagán, J. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.11.008 · Cited by 30
Zimmer, A., Teixeira, R. B., Bonetto, J. H. P., Siqueira, R., Carraro, C. C., Donatti, L. M., Hickmann, A. R., Litvin, I. E., Godoy, A. E. G., Araújo, A. S. D. R., et al. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2937-1 · Cited by 30
“In this case, and in the presence of reactive species, NO can react rapidly with O2 to generate peroxynitrite (ONOO−), dramatically increasing oxidative damage [2, 9, 17] and aggravating endothelial dysfunction.”
Use of Computational Biochemistry for Elucidating Molecular Mechanisms of Nitric Oxide Synthase
Bignon, E., Rizza, S., Filomeni, G., & Papaleo, E. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.03.011 · Cited by 30
“…mainly in vascular endothelium to guarantee vasorelaxation [23,24], cellular proliferation, white blood cells adhesion, and platelet aggregation [24,25]. cNOSs exert their functions functions mainly by producing low, controlled fl uxes of NO, whereas iNOS acts mainly as a cytotoxic, antimicrobial…”
BackgroundKezele, T. G., & Ćurko‐Cofek, B. (2022) · Nutrients · doi:10.3390/nu14214533 · Cited by 30
Dietary Nitrate from Plant Foods: A Conditionally Essential Nutrient for Cardiovascular Health
Pinaffi-Langley, A. C. D. C., Dajani, R. M., Prater, M. C., Nguyen, H. V. M., Vrancken, K., Hays, F. A., & Hord, N. G. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2023.100158 · Cited by 30
Sumner, S., Snyder, R. W., Wingard, C. J., Mortensen, N. P., Holland, N. A., Shannahan, J. H., Dhungana, S., Pathmasiri, W., Han, L., Lewin, A. H., et al. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3110 · Cited by 30
“eNOS is responsible for most of the vascular NO production, which protects the vasculature from oxidative stress (Forstermann and Munzel, 2006).”
BackgroundKorkmaz, S., Loganathan, S., Mikles, B., Radovits, T., Barnucz, E., Hirschberg, K., Li, S., Hegedűs, P., Páli, S., Weymann, A., et al. (2012) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412455696 · Cited by 30
“Moreover, in higher concentration, peroxynitrite-mediated oxidation of tetrahydrobiopterin, an essential NO synthase (NOS) cofactor, leads to the dysfunction of NOS, thereby causing endothelial NOS uncoupling.(30) Pharmacological activation of sGC by cinaciguat can potently bind and activate the oxidized and/or heme-f…”
BackgroundSuh, J., Choi, D., Chang, H., Cho, Y., Youn, T., Chae, I., Kim, K., Kim, C.-H., Kim, H.-S., Oh, B., et al. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.1.16 · Cited by 30
“The impairment of endothelium-dependent dilatation, which is accompanied by the alteration in the expression and/or activity of the endothelial NO synthase, has consistently been observed in conduit arteries and resistance vessels as an effect of hypertension (3, 4).”
BackgroundMokhtar, S. S., Vanhoutte, P. M., Leung, S. W. S., Yusof, M. I., Sulaiman, W. A. W., Saad, A. Z. M., Suppıan, R., & Rasool, A. H. G. (2016) · Nitric Oxide · doi:10.1016/j.niox.2015.12.007 · Cited by 31
Khan, A., Dawoud, H., & Maliñski, T. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s152822 · Cited by 30
“excessive O 2 − and ONOO− can oxidize tetrahydrobiopterin, BH 4 , an important cofactor of eNOS and a stabilizer of eNOS dimer.(27,28) In the absence of BH 4 , eNOS produces mostly O 2 −.”
BackgroundCTRP13 Preserves Endothelial Function by Targeting GTP Cyclohydrolase 1 in Diabetes
Wang, C., Chao, Y., Xu, W., Liang, M., Deng, S., Zhang, D., & Huang, K. (2019) · Diabetes · doi:10.2337/db19-0635 · Cited by 30
“eNOS is responsible for vascular NO production (23).”
Background
Metadata
- Authors
- Förstermann, U., & Münzel, T.
- Affiliations
- From the Departments of Pharmacology (U.F.) and Internal Medicine II (Cardiology) (T.M.), Johannes Gutenberg University Hospitals, Mainz, Germany.
- Venue
- Circulation
- Published
- 2006-04-04
- Volume
- 113
- Issue
- 13
- Pages
- 1708-1714
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2146190354
- Cited by
- 1,957
- References
- 67
- Citations by year
- 2026: 93 · 2025: 76 · 2024: 99 · 2023: 86 · 2022: 110 · 2021: 113 · 2020: 110 · 2019: 89 · 2018: 105 · 2017: 105 · 2016: 117 · 2015: 101 · 2014: 123 · 2013: 98 · 2012: 85
- FWCI
- 62.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- endothelial nitric oxide synthase, nitric oxide, tetrahydrobiopterin, eNOS uncoupling, NADPH oxidase, reactive oxygen species, superoxide, peroxynitrite, oxidative stress, cardiovascular risk factors, hypertension, hypercholesterolemia, diabetes mellitus, smoking, folic acid, vitamin C, L-arginine
- MeSH terms
- Animals, Endothelium, Vascular, Humans, Nitric Oxide, Vascular Diseases, Reactive Oxygen Species, Oxidative Stress, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review